Evidence map›Paper›PMID 27774464›Full record

ArticleHypoxia (Auckland, N.Z.)2014

Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer.

Jerry H Fuady, Mattia R Bordoli, Irene Abreu-Rodríguez, Glen Kristiansen, David Hoogewijs, Daniel P Stiehl, Roland H Wenger

Open access · diamondAbstract read
In one paragraph

Article in Hypoxia (Auckland, N.Z.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CCN5/WISP2 and metabolic diseases.Journal of cell communication and signaling · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jerry H FuadyInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
Mattia R BordoliInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
Irene Abreu-RodríguezInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
Glen KristiansenUniversity Hospital Bonn, Institute of Pathology, Bonn, Germany.
David HoogewijsInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
Daniel P StiehlInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
Roland H WengerInstitute of Physiology and Zurich Center for Human Physiology, University of Zurich, Zurich, Switzerland.
University of Zurich · CHUniversity Hospital Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia and the hypoxia-inducible factor (HIF) signaling pathway trigger the expression of several genes involved in cancer progression and resistance to therapy. Transcriptionally active HIF-1 and HIF-2 regulate overlapping sets of target genes, and only few HIF-2 specific target genes are known so far. Here we investigated oxygen-regulated expression of Wnt-1 induced signaling protein 2 (WISP-2), which has been reported to attenuate the progression of breast cancer. WISP-2 was hypoxically induced in low-invasive luminal-like breast cancer cell lines at both the messenger RNA and protein levels, mainly in a HIF-2α-dependent manner. HIF-2-driven regulation of the

Indexed as

invasionmetastasismotilityoxygentranscriptional regulationtumor

Identifiers

PMID27774464
PMCPMC5045054
OpenAlexW1999618694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.